Leap Therapeutics, Inc. (LPTX)
USD 2.9
(-6.75%)
USD 2.9
(-6.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -43.75 Million | -49.04 Million | -35.15 Million | -25.95 Million | -26.9 Million | -26.03 Million |
| Net Income | -81.41 Million | -54.59 Million | -40.58 Million | -27.51 Million | -32.9 Million | -23.13 Million |
| Depreciation & Amortization | 427 Thousand | 16 Thousand | 29 Thousand | 34 Thousand | 47 Thousand | 49 Thousand |
| Deferred income taxes | -712 Thousand | 152 Thousand | 379 Thousand | -738 Thousand | -3000.00 | 20 Thousand |
| Stock-based compensation | 5.12 Million | 5.18 Million | 3.48 Million | 2.61 Million | 3.89 Million | 3.46 Million |
| Change in working capital | 2.51 Million | -651 Thousand | 1.01 Million | -990 Thousand | 1.33 Million | 871 Thousand |
| Other non-cash items | 30.3 Million | 855 Thousand | 527 Thousand | 634 Thousand | 732 Thousand | -7.3 Million |
| Investing Cash Flow | 48.96 Million | - | - | 25 Thousand | -85 Thousand | - |
| Investments in PPE | - | - | - | - | -100 Thousand | - |
| Acquisitions | 50.36 Million | - | - | 25 Thousand | 15 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.39 Million | - | - | 25 Thousand | 15 Thousand | - |
| Financing Cash Flow | -30 Thousand | -210 Thousand | 98.03 Million | 73.99 Million | 14.81 Million | 15.9 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | -303 Thousand | -359 Thousand | - |
| Common Stock Repurchased | -1000.00 | - | - | - | 1 Million | - |
| Common Stock Issuance | -29 Thousand | -210 Thousand | 97.22 Million | 48.51 Million | 15.25 Million | 15.03 Million |
| Other Financing Activities | -1000.00 | -210 Thousand | 813 Thousand | 25.78 Million | -437 Thousand | 872 Thousand |
| Accounts receivables | 1.3 Million | -1 Million | -1.15 Million | 117 Thousand | 643 Thousand | 780 Thousand |
| Accounts payables | 712 Thousand | 945 Thousand | 3.9 Million | -2.6 Million | 1.08 Million | 368 Thousand |
| Inventory | - | 1 Million | 1.15 Million | -117 Thousand | -643 Thousand | - |
| Other working capital | 497 Thousand | -1.59 Million | -2.88 Million | 1.61 Million | 247 Thousand | 503 Thousand |
| Cash at beginning of period | 65.5 Million | 114.91 Million | 52.07 Million | 3.89 Million | 16.28 Million | 25.73 Million |
| Cash at end of period | 70.64 Million | 65.5 Million | 114.91 Million | 52.07 Million | 3.89 Million | 16.28 Million |
| Capital Expenditure | - | - | - | - | -100 Thousand | - |
| Effect of forex changes on cash | -43 Thousand | -162 Thousand | -33 Thousand | 115 Thousand | -223 Thousand | 674 Thousand |
| Net cash flow / Change in cash | 5.14 Million | -49.41 Million | 62.84 Million | 48.18 Million | -12.39 Million | -9.45 Million |
| Free Cash Flow | -43.75 Million | -49.04 Million | -35.15 Million | -25.95 Million | -27 Million | -26.03 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -20.12 Million | -13.82 Million | -81.41 Million | -12.46 Million | -13.69 Million | -13.39 Million |
| Depreciation & Amortization | 202 Thousand | 5000.00 | 427 Thousand | 110 Thousand | -199 Thousand | 106 Thousand |
| Deferred income taxes | - | - | -712 Thousand | -501 Thousand | 501 Thousand | - |
| Stock-based compensation | 1.37 Million | 1.24 Million | 5.12 Million | 1.25 Million | 1.3 Million | 1.26 Million |
| Change in working capital | 5.19 Million | -3.06 Million | 2.51 Million | 1.66 Million | 1.3 Million | 1.63 Million |
| Other non-cash items | -3.55 Million | 4 Million | 30.3 Million | -439 Thousand | 306 Thousand | 195 Thousand |
| Investing Cash Flow | - | - | 48.96 Million | -100.72 Million | - | -348 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | 50.36 Million | -100.72 Million | - | 50.36 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -1.39 Million | - | - | -50.71 Million |
| Financing Cash Flow | 37.11 Million | 29 Thousand | -30 Thousand | - | -1000.00 | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1000.00 | - | - | - |
| Common Stock Issuance | -2.88 Million | 29 Thousand | -29 Thousand | - | - | - |
| Other Financing Activities | 39.99 Million | 29 Thousand | -1000.00 | - | -1000.00 | - |
| Accounts receivables | -251 Thousand | -247 Thousand | 1.3 Million | 23 Thousand | 1.85 Million | -297 Thousand |
| Accounts payables | 5.07 Million | -2.38 Million | 712 Thousand | 1.71 Million | -624 Thousand | 1.81 Million |
| Inventory | - | - | - | 1.81 Million | - | - |
| Other working capital | 371 Thousand | -432 Thousand | 497 Thousand | -1.89 Million | 70 Thousand | 122 Thousand |
| Cash at beginning of period | 54.92 Million | 70.64 Million | 65.5 Million | 80.74 Million | 91.41 Million | 102.03 Million |
| Cash at end of period | 78.47 Million | 54.92 Million | 70.64 Million | 70.64 Million | 80.74 Million | 91.41 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 112 Thousand | -235 Thousand | -43 Thousand | 280 Thousand | -183 Thousand | -90 Thousand |
| Net cash flow / Change in cash | 23.55 Million | -15.72 Million | 5.14 Million | -10.1 Million | -10.67 Million | -10.62 Million |
| Free Cash Flow | -13.67 Million | -15.51 Million | -43.75 Million | -10.38 Million | -10.48 Million | -10.18 Million |
BRI
7133
BLR
PMC
CTTAY
KKES